Stroke risk in women with atrial fibrillation
Buhari H, Fang J, Han L, Austin PC, Dorian P, Jackevicius CA, Yu AYX, Kapral MK, Singh SM, Tu K, Ko DT, Atzema CL, Benjamin EJ, Lee DS, Abdel-Qadir H. Eur Heart J. 2023; Aug 30 [Epub ahead of print].
Publications
Trends in B-type natriuretic peptide testing: a population-based cohort study
Doumouras BS, Abdel-Qadir H, McNaughton CD, Kavsak PA, Austin PC, Wang X, Chu A, Udell JA, Ross HJ, Lee DS. JACC Heart Fail. 2023; Jul 19 [Epub ahead of print].
Statin use and stroke rate in older adults with atrial fibrillation: a population-based cohort study
Shweikialrefaee B, Ko DT, Fang J, Pang A, Austin PC, Dorian P, Singh SM, Jackevicius CA, Tu K, Lee DS, Abdel-Qadir H.
Sex-based differences in severe outcomes, including cardiovascular hospitalization, in adults with COVID-19 in Ontario, Canada
Behrouzi B, Sivaswamy A, Chu A, Ferreira-Legere LE, Abdel-Qadir H, Atzema CL, Jackevicius C, Kapral MK, Wijeysundera HC, Farkouh ME, Ross HJ, Ha ACT, Tadrous M, Paterson M, Gershon AS, Dzavík V, Fang J, Kaul P, van Diepen S, Goodman SG, Ezekowitz JA, Bainey KR, Ko DT, Austin PC, McAlister FA, Lee DS, Udell JA. JACC Adv. 2023; May 10 [Epub ahead of print].
The association of sodium-glucose cotransporter 2 inhibitors with cardiovascular outcomes in anthracycline-treated patients with cancer
Abdel-Qadir H, Carrasco R, Austin PC, Chen Y, Zhou L, Fang J, Su HMH, Lega IC, Kaul P, Neilan TG, Thavendiranathan P. JACC CardioOncol. 2023; 5(3):318-28. Epub 2023 May 2.
Comorbidity-stratified estimates of 30-day mortality risk by age for unvaccinated men and women with COVID-19: a population-based cohort study
Abdel-Qadir H, Austin PC, Sivaswamy A, Chu A, Wijeysundera HC, Lee DS. BMC Public Health. 2023; 23(1):482. Epub 2023 Mar 13.
Association of race and ethnicity with obstructive coronary artery disease
Rooprai J, Qiu F, PorterJ, Abdel-Qadir H, Godoy LC, Jackevicius CA, Lee DS, Madan M, Shah BR, Sud M, Wijeysundera HC, Ko DT. JACC Adv. 2023; 2(1):100161. Epub 2023 Jan 11.
Primary care clinical volumes, cholesterol testing, and cardiovascular outcomes
Udell JA, Brickman AR, Chu A, Ferreira-Legere LE, Sheth MS, Ko DT, Austin PC, Abdel-Qadir H, Ivers NM, Bhatia RS, Farkouh ME, Stukel TA, Tu JV. Can J Cardiol. 2023; 39(3):340-9. Epub 2022 Dec 23.
Eligibility and implementation of rivaroxaban for secondary prevention of atherothrombosis in clinical practice-insights from the CANHEART study
Sheth MS, Yu B, Chu A, Porter J, Tam DY, Ferreira-Legere LE, Goodman SG, Farkouh ME, Ko DT, Abdel-Qadir H, Udell JA. J Am Heart Assoc. 2022; 11(24):e026553. Epub 2022 Dec 14.
Post-acute healthcare burden after SARS-CoV-2 infection: a retrospective cohort study
McNaughton CD, Austin PC, Sivaswamy A, Fang J, Abdel-Qadir H, Daneman N, Udell JA, Wodchis WP, Mostarac I, Lee DS, Atzema CL. CMAJ. 2022; 194:E1368-76. Epub 2022 Oct 17.